Bicocca Open Archive

Logo unimib boa
CRIVELLARO, CINZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.030
EU - Europa 3.132
AS - Asia 1.106
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
AF - Africa 8
Totale 10.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.934
IT - Italia 1.012
DE - Germania 488
CN - Cina 487
SE - Svezia 393
SG - Singapore 340
IE - Irlanda 310
RU - Federazione Russa 238
UA - Ucraina 173
GB - Regno Unito 131
HK - Hong Kong 110
CA - Canada 95
AT - Austria 92
DK - Danimarca 61
FI - Finlandia 56
VN - Vietnam 56
FR - Francia 50
IN - India 50
BE - Belgio 24
TR - Turchia 24
NL - Olanda 20
PL - Polonia 20
CZ - Repubblica Ceca 19
AU - Australia 16
CH - Svizzera 16
KR - Corea 10
BG - Bulgaria 9
ES - Italia 8
EU - Europa 7
ID - Indonesia 7
IR - Iran 7
JP - Giappone 6
BR - Brasile 5
A2 - ???statistics.table.value.countryCode.A2??? 4
PT - Portogallo 4
SC - Seychelles 4
CL - Cile 3
HU - Ungheria 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
RO - Romania 2
AM - Armenia 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 10.315
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.578
Chandler 466
Fairfield 454
Woodbridge 415
Frankfurt am Main 358
Wilmington 357
Houston 326
Ashburn 301
Dublin 297
Milan 294
Singapore 275
Dearborn 234
Seattle 186
Jacksonville 169
Cambridge 158
New York 156
Santa Clara 117
Princeton 111
Shanghai 102
Lissone 100
Hong Kong 95
Vienna 92
Nanjing 86
Altamura 51
Lawrence 49
Fremont 38
Boardman 33
Guangzhou 33
San Diego 32
Beijing 31
Monza 31
Ottawa 31
Nanchang 29
Lachine 27
Falls Church 26
Helsinki 24
London 24
Brussels 21
Dong Ket 21
Shenyang 21
Rome 19
Andover 18
Brno 17
Jinan 17
Kunming 17
Dallas 16
Toronto 16
Munich 15
Pune 15
Tianjin 15
Genoa 14
Edmonton 13
Kraków 12
Melbourne 12
Hebei 11
Norwalk 11
Segrate 11
Lanzhou 10
Amsterdam 9
Changsha 9
Detroit 9
Hangzhou 9
Hefei 9
Jiaxing 9
Kiev 9
Kocaeli 8
Mountain View 8
Plovdiv 8
Bari 7
Biella 7
Como 7
Jakarta 7
Lecco 7
Los Angeles 7
Ningbo 7
Carate Brianza 6
Chicago 6
Huizen 6
Leawood 6
Paris 6
Sesto San Giovanni 6
Vadodara 6
Verdellino 6
Zhengzhou 6
Alessandria 5
Catania 5
Madrid 5
San Mateo 5
Taizhou 5
Washington 5
Cornate d'Adda 4
Daejeon 4
Enterprise 4
Garbagnate Milanese 4
Gorgonzola 4
Istanbul 4
Lausanne 4
Messina 4
Naples 4
Newark 4
Totale 7.768
Salva come PNG Salva come JPEG
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 375
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 318
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 316
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 312
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 307
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 306
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 298
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 284
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 267
Anatomical correlates of reading in the elderly brain: an FDG-PET analysis of the reading performance in Alzheimer's Disease 238
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 238
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 231
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 225
Sentinel node biopsy in endometrial cancer: an update 225
Motion management in PET/CT: Technological solutions 218
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction 213
Respiratory motion management in PET/CT: applications and clinical usefulness 210
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 207
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 205
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 205
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 197
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 194
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 193
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 187
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 185
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 185
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 184
Intrathoracic splenosis: Evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT 177
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 175
Focal bone lesions in hiv-positive patient treated with tenofovir 174
Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study 174
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 174
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 172
[(11)C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 170
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 166
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 165
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 153
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 138
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 136
Clinical evidence on PET/CT for radiation therapy planning in prostate cancer 131
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 129
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 129
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 126
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 126
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 124
PET-CT for treatment planning in prostate cancer 123
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 122
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 113
Molecular imaging in prostate cancer: [11C]choline PET/CT 110
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 100
Respiratory Gating and the performance of PET/CT in pulmonary lesions 100
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 97
Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy 94
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 94
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 79
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum 75
PET-Guided target delineation in a patient with lung cancer. 73
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 68
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 64
Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature 56
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation 43
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6 38
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups 35
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 31
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 29
A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting 24
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers 12
Totale 10.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.979
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.283 0 0 0 0 174 216 259 166 185 105 138 40
2020/20211.781 56 73 187 183 163 183 147 180 142 156 141 170
2021/20221.107 107 140 110 116 64 71 56 54 53 92 99 145
2022/20231.834 182 531 152 219 112 281 13 108 97 45 53 41
2023/20241.307 53 54 74 77 140 294 235 70 67 38 21 184
2024/2025968 155 334 169 136 174 0 0 0 0 0 0 0
Totale 10.842